Illumina Debuts Noninvasive Prenatal Testing Software
The updated software includes an innovative method for processing samples and is designed for larger batches of 48 samples, versus the current 16 samples.
Read MoreSearch Results for: genetic testing
The Evolution of the PD-L1 Testing Market
The dynamic PD-L1 space is providing opportunities to undertake real-time market analysis and ultimately improve our understanding of novel biomarker adoption.
Read More
Illumina, Children’s Hospital of Philadelphia Launch Study
The study will use whole-genome sequencing as part of the diagnostic process for leukodystrophies.
Read More
Sequencing Architecture Seeks to Usher in the $100 Genome
Illumina’s NovaSeq series has been designed to allow a broad set of researchers to access next-generation sequencing technology and more easily conduct large-scale genomics projects with greater sample volumes, or more breadth and depth in the genome.
Read More
LabCorp Tapped as US Distributor of Preterm Birth Risk Blood Test
The test can help physicians identify women at increased risk for premature delivery as early as 19 weeks into the pregnancy.
Read More